Arrowhead Pharmaceuticals Inc (ARWR) — the peer cohort

As of 2026-09-17 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Arrowhead Pharmaceuticals Inc ranks 9 of 16 in its cohort on the Closelook composite (46/100) — the cohort is led by ageas SA/NV at 69/100.

Name	Composite	Momentum	Quality	Valuation	Signal	Off 52w high
ARWR Arrowhead Pharmaceuticals Inc	46	49	33	13	info	31.1%
0B2.DE Bawag Group AG	43	81	35	34	ok	3%
0ZC.DE ZSCALER INC. DL-,001	40	63	37	25	—	—
1N8.DE ADYEN N.V. EO-01	60	34	84	65	warn	42.4%
2NN.DE NN Group N.V.	46	77	19	65	ok	1.7%
8TRA.DE Traton SE	42	72	19	74	info	11.9%
ABB.ST ABB Ltd	51	58	62	25	info	11.7%
ABEV Ambev SA ADR	58	46	71	77	ok	13.1%
ABVX.PA Abivax SA	34	38	1	54	info	34.9%
ACKB.BR Ackermans & Van Haaren NV	39	50	32	70	ok	7.4%
ACLN.SW Accelleron Industries AG	59	32	72	52	info	20.2%
AD.AS Koninklijke Ahold Delhaize NV	48	25	33	81	warn	22%
ADC Agree Realty Corporation	38	36	43	31	info	15.7%
AER AerCap Holdings NV	47	53	54	63	info	10.2%
AG First Majestic Silver Corp	62	19	65	59	info	42.7%
AGS.BR ageas SA/NV	69	81	84	86	ok	0.5%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-17

Quick answers

Who are Arrowhead Pharmaceuticals Inc's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Bawag Group AG (0B2.DE), ZSCALER INC. DL-,001 (0ZC.DE), ADYEN N.V. EO-01 (1N8.DE), NN Group N.V. (2NN.DE), Traton SE (8TRA.DE), ABB Ltd (ABB.ST), Ambev SA ADR (ABEV), Abivax SA (ABVX.PA) and others.

How does ARWR score against its peers?

Arrowhead Pharmaceuticals Inc's composite reads 46/100, ranking 9 of 16 in its cohort as of 2026-09-17; the cohort's highest composite is ageas SA/NV at 69/100. Closelook scores are research diary readings, not ratings or advice.